News

($ in millions, except per share amounts, and where indicated)

Quarters Ended
June 30,

Percentage
Inc/(Dec)

Six Months Ended
June 30,

Percentage
Inc/(Dec)

Pfizer Inc. (NYSE: PFE) today announced data from a Phase 2 study investigating its hexavalent capsular polysaccharide (CPS) conjugate Group B Streptococcus (GBS) vaccine candidate, GBS6, being

Exxon Mobil Corporation (NYSE: XOM) will release its second quarter 2023 financial results on Friday, July 28, 2023. The company will issue a press release via Business Wire, and it will be

Exxon Mobil Corporation (NYSE: XOM) today announced it has entered into a definitive agreement to acquire Denbury Inc. (NYSE: DEN), an experienced developer of carbon capture, utilization and

Bunge (NYSE: BG) and Chevron’s Renewable Energy Group Inc., a subsidiary of Chevron Corporation (NYSE: CVX), acquired Chacraservicios S.r.l., based in Argentina, from the Italian-based Adamant

NIKE, Inc. (NYSE:NKE) today reported financial results for its fiscal 2023 fourth quarter and full year ended May 31, 2023.

• 
  Full year reported revenues were $51.2 billion, up 10 percent

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a once-weekly, human growth

American Express Company (NYSE:AXP) today announced that Jeffrey C. Campbell, Vice Chairman and Chief Financial Officer, has decided to retire from the company. He will step down as the company’s

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for fidanacogene elaparvovec for the

Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, July 28, 2023, at 11:00 a.m. ET (8:00 a.m. PT).

Pfizer Inc. (NYSE: PFE) today announced its decision to continue to progress one oral late-stage glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate toward further clinical development

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved LITFULO^™ (ritlecitinib), a once-daily oral treatment, for individuals 12 years of age and older

American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, July 21, 2023, to discuss second-quarter 2023 financial results

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.41 third-quarter 2023 dividend on the company’s common stock, payable September 5, 2023, to holders of the Common

Chevron New Energies Japan GK (Chevron New Energies Japan), a subsidiary of Chevron U.S.A. Inc., and Mitsui Oil Exploration Co., Ltd (MOECO) today announced execution of definitive agreements to

Pfizer (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved TALZENNA (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, August 1, 2023. The purpose

Marvel’s Avengers – including Captain America, Iron Man, Black Panther, Thor, Captain Marvel, Black Widow, Hulk and more – have been pop culture staples since the mighty Super Heroes’ comic book

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with William Pao, Chief Development Officer, Executive Vice President, at the

NIKE, Inc. (NYSE: NKE) plans to release its fourth quarter fiscal 2023 financial results on Thursday, June 29, 2023, at approximately 1:15 p.m. PT, following the close of regular stock market

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 program comprising the REVISIT (NCT03329092) and ASSEMBLE (NCT03580044) studies evaluating the efficacy, safety, and

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F

Chevron Corporation (NYSE: CVX) today provided an overview of the company’s business plans and operations at its annual meeting of stockholders.

“We’re always pleased to be able to address our

Walmart Inc. (NYSE: WMT) announced today that company leadership will participate in upcoming investor events, with several including live webcasts on Walmart’s investor relations website at

Pfizer Inc. (NYSE: PFE) today announced that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has met its primary endpoints, having demonstrated statically significant